Literature DB >> 915898

Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.

K H Baggaley, R Fears, R M Hindley, B Morgan, E Murrell, D E Thorne.   

Abstract

A series of compounds related to ethyl 4-benzyloxybenzoate was synthesized and evaluated for potential hypolipidemic activity in rats. Structure--activity relationships are discussed in terms of cholesterol-lowering activity together with effects on weight gain and liver lipids. A number of the compounds inhibited cholesterol and free fatty acid biosynthesis from [1-14C]acetate in rat liver slices in vitro. Ethyl 4-benzyloxybenzoate, ethyl-4-benzyloxybenzoic acid, ethyl 4-p-bromobenzyloxybenzoates, and 4-o-methoxybenzyloxyphenyl acetate exhibited the most favorable spectrum of activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915898     DOI: 10.1021/jm00221a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.

Authors:  Delphine Lamoral-Theys; Laurent Pottier; Frédéric Kerff; François Dufrasne; Fabien Proutière; Nathalie Wauthoz; Philippe Neven; Laurent Ingrassia; Pierre Van Antwerpen; Florence Lefranc; Michel Gelbcke; Bernard Pirotte; Jean-Louis Kraus; Jean Nève; Alexander Kornienko; Robert Kiss; Jacques Dubois
Journal:  Bioorg Med Chem       Date:  2010-04-21       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.